PVLA Palvella Therapeutics, Inc. - Common Stock
$152,77
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 4, 2026
Zakres 52 tyg.
$46–$161
93% of range
Ocena Analityków
BUY
22 analysts
Cena Docelowa
$231
+51% upside
P/E (TTM)
-41.2
ROE
-110.1%
Marża Zysku Netto
-1610.6%
PVLA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$152.77
Kapitalizacja Rynkowa
$1.89B
P/E (TTM)
-41.2
EPS (TTM)
$-3.71
Przychody (TTM)
$43M
Stopa dywidendy
—
ROE
-110.1%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$46 – $161
PVLA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$43M
2017-12-31
→
2023-12-31
EPS
$-3.71
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2017-12-31
→
2022-12-31
Marże
-1610.6%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
PVLA
Mediana porównawcza
P/E (TTM)
-41.2
55.4
P/S (TTM)
96.6
7.7
P/B
67.6
7.1
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
PVLA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-1490.4%
—
Net Profit Margin (Marża Zysku Netto)
-1610.6%
-2.0%
ROA
-56.5%
-32.7%
ROE
-110.1%
-37.9%
ROIC
-137.9%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
PVLA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.2
7.4
Quick Ratio (Wskaźnik Szybkości)
5.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
PVLA
Mediana porównawcza
Revenue YoY (Przychody R/R)
65.3%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
13.4%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
PVLA
Mediana porównawcza
PVLA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
22 analityków
- Mocne kupno 6 27,3%
- Kup 15 68,2%
- Trzymaj 1 4,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
15 analityków · 2026-08-17
Mediana
$232.00
← Poniżej wszystkich celów
$152.77
Niski
$205.00
Wysoki
$270.00
Średni cel
$232.00
+51,9%
Średnia cel
$230.53
+50,9%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.37%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-1.52 | $-1.18 | -0.34% |
| 31 marca 2026 | $-1.20 | $-0.95 | -0.25% |
| 31 grudnia 2025 | $-1.07 | $-0.93 | -0.14% |
| 30 września 2025 | $-1.03 | $-0.86 | -0.17% |
| 30 czerwca 2025 | $-0.86 | $-0.76 | -0.10% |
| 31 marca 2025 | $-0.74 | $-1.24 | 0.50% |
| 31 grudnia 2024 | $-2.72 | $-0.66 | -2.1% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| VERA | — | -10.9 | — | — | -55.9% | — |
| MLYS | $2.96B | -15.8 | — | — | -32.2% | — |
| VCEL | $1.82B | 112.5 | 16.4% | 6.0% | 5.0% | 74.4% |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| R&D Expense | $23M | $8M | $9M | $53M | $67M | $47M | $55M | $41M | $22M | $20M | $8M | $6M | |
| SG&A Expense | $16M | $6M | $3M | $16M | $17M | $17M | $18M | $18M | $18M | $9M | $8M | $7M | |
| Operating Expenses | $39M | $14M | $12M | $69M | $83M | $63M | $73M | $60M | $40M | $29M | $17M | $13M | |
| Operating Income | $-39M | $-14M | $-12M | $-43M | $-52M | $-34M | $-27M | $-31M | $-15M | $-23M | $-14M | $-7M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Other Non-op | $727.0K | $-131.0K | $712.0K | $1M | $2M | $-4M | $-26.0K | $2M | $-2M | $120.0K | $10.9K | $3.0K | |
| Pretax Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-17M | $-23M | $-14M | $-10M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $164.0K | $0 | $-312.0K | $1M | $162.0K | $203.9K | $-18 | |
| Net Income | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| EPS (Basic) | $-3.71 | $-7.83 | $2.19 | $-0.45 | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.71 | $-7.83 | $2.17 | · | $-0.71 | $-0.68 | · | · | · | · | · | · | |
| Shares (Basic) | 11,251,250 | 2,225,934 | 1,770,167 | 74,172,000 | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 11,251,250 | 2,225,934 | 1,793,980 | · | 64,547,000 | 54,481,000 | · | · | · | · | · | · | |
| EBITDA | $-39M | $-14M | · | $-41M | · | $-34M | $-27M | $-31M | $-15M | · | · | · |
Bilans 24
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $84M | $7M | $39M | $118M | $70M | $62M | $75M | $38M | $29M | $29M | $18M | |
| Short-term Investments | $0 | · | $9M | $21M | $0 | $0 | $42M | $53M | $35M | $0 | · | · | |
| Receivables | $0 | $358.0K | $0 | $6M | $3M | $2M | $7M | $3M | $16M | $57.0K | $0 | $0 | |
| Prepaid Expense | $1M | $2M | $198.0K | $3M | $7M | $4M | $4M | $5M | $2M | $3M | $2M | $1M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Assets | $59M | $88M | $8M | $73M | $128M | $76M | $115M | $135M | $90M | $33M | $32M | $20M | |
| PP&E (Net) | · | · | $0 | $17M | $19M | $22M | $20M | $5M | $4M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | · | $27M | $27M | $28M | $23M | $8M | $7M | $5M | $4M | $4M | |
| Accum. Depreciation | · | · | · | $10M | $8M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | $0 | $1M | $3M | $3M | $3M | $910.0K | $130.0K | $126.0K | $126.8K | · | |
| Total Assets | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Accounts Payable | $5M | $5M | $936.0K | $4M | $9M | $2M | $6M | $3M | $2M | $2M | $1M | · | |
| Accrued Liabilities | · | · | · | · | · | $8M | $10M | $9M | $6M | $4M | $2M | $986.6K | |
| Current Liabilities | $11M | $12M | $2M | $37M | $51M | $22M | $27M | $48M | $46M | $8M | $3M | $4M | |
| Capital Leases | $431.0K | $0 | $0 | $12M | $14M | $16M | $15M | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | $6.0K | $0 | $27.0K | $37.0K | $47.0K | $23.9K | $334.0K | |
| Total Liabilities | $32M | $26M | $11M | $68M | $103M | $74M | $90M | $101M | $92M | $10M | $3M | $4M | |
| Common Stock | $12.0K | $11.0K | $0 | $74.0K | $72.0K | $56.0K | $55.0K | $54.0K | $45.0K | $43.0K | $39.8K | $29.3K | |
| Paid-in Capital | $163M | $156M | $2M | $319M | $307M | · | · | · | · | · | $112M | $85M | |
| Retained Earnings | $-135M | $-94M | $-76M | $-290M | $-257M | $-211M | $-174M | $-147M | $-120M | $-103M | $-80M | $-66M | |
| AOCI | $83.0K | $3.0K | $0 | $-254.0K | $829.0K | $-295.0K | $-2M | $-3M | $-5M | $-2M | $-1M | $-843.1K | |
| Stockholders' Equity | $28M | $63M | $-74M | $-94M | $51M | $31M | $51M | $40M | $12M | $25M | $31M | $18M | |
| Liabilities + Equity | $60M | $88M | $8M | $95M | $154M | $105M | $141M | $141M | $104M | $35M | $34M | $22M | |
| Shares Outstanding | 12,380,933 | 11,012,105 | 1,770,167 | 74,519,103 | 72,222,661 | 56,003,000 | 55,212,437 | 54,151,219 | 45,017,062 | 43,058,827 | 39,833,023 | 29,279,522 |
Przepływy pieniężne 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $2M | $3M | $2M | · | · | · | · | · | · | · | |
| Stock-based Comp | $6M | $830.0K | $603.0K | $4M | $5M | $5M | $5M | $5M | $3M | $2M | $1M | $571.4K | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | $0 | $-164.0K | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-34M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-25M | $-11M | $-14M | $-60M | $-8M | $-46M | $-52M | $-1M | $50M | $-14M | $-13M | $-5M | |
| CapEx | · | · | $171.0K | $1M | $949.0K | $3M | $2M | $2M | $2M | $560.0K | $620.7K | $267.4K | |
| Investing Cash Flow | · | · | $12M | $-21M | $-949.0K | $39M | $10M | $-9M | $-46M | · | · | · | |
| Stock Issued | · | · | $20M | $7M | $38M | $10M | · | · | · | · | $26M | $12M | |
| Net Stock Activity | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-660.0K | $87M | $5M | $7M | $59M | $10M | $32M | $49M | $4M | · | · | · | |
| Net Change in Cash | $-26M | $76M | $-9M | $-79M | $47M | $8M | $-13M | $37M | $9M | $6.0K | $11M | $15M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $51.7K | |
| Free Cash Flow | · | · | · | $-61M | · | $-49M | $-55M | $-3M | $48M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1490.4% | · | · | -167.8% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| Net Margin | -1610.6% | · | · | -128.5% | · | -127.0% | -55.0% | -91.9% | -69.8% | · | · | · | |
| Pretax Margin | -1610.6% | · | · | -128.5% | · | -126.4% | -55.0% | -93.0% | -65.5% | · | · | · | |
| EBITDA Margin | -1490.4% | · | · | -157.1% | · | -115.7% | -58.7% | -105.9% | -57.7% | · | · | · | |
| ROA | -56.5% | -36.4% | · | -26.7% | · | -30.3% | -17.9% | -21.8% | -25.4% | · | · | · | |
| ROE | -110.1% | 140.6% | · | -92.1% | · | -99.7% | -70.8% | -59.3% | -96.0% | · | · | · | |
| ROIC | -137.9% | -22.5% | · | -155.7% | · | -109.8% | -52.9% | -76.3% | -135.1% | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.3 | · | 2.0 | · | 3.4 | 4.3 | 2.8 | 2.0 | · | · | · | |
| Quick Ratio | 5.1 | 7.0 | · | 1.8 | · | 3.3 | 4.1 | 2.7 | 1.9 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.2 | · | 0.2 | 0.3 | 0.2 | 0.4 | · | · | · | |
| Receivables Turnover | 14.5 | · | · | 5.7 | · | 6.9 | 9.8 | 3.2 | 3.2 | · | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 65.3% | -17.6% | 7.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | 13.4% | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $43M | $26M | $31M | $29M | $46M | $29M | $25M | $6M | $3M | $5M | |
| Net Income TTM | $-42M | $-17M | $19M | $-33M | $-46M | $-37M | $-25M | $-27M | $-18M | $-23M | $-14M | $-10M | |
| Market Cap | $1.30B | $132M | · | $6.20B | · | $11.20B | $15.99B | $11.52B | $27.19B | · | · | · | |
| P/E | -28.2 | -1.5 | 6.7 | -118.9 | -425.9 | -294.1 | · | · | · | · | · | · | |
| P/S | 66.2 | 6.8 | · | 239.4 | · | 382.0 | 345.5 | 396.0 | 1075.8 | · | · | · | |
| P/B | 46.3 | 2.1 | · | 222.0 | · | 361.0 | 311.4 | 288.6 | 2359.9 | · | · | · | |
| P / Tangible Book | 46.3 | 2.1 | · | · | 430.3 | 361.0 | · | · | · | · | · | · | |
| P / Cash Flow | -51.8 | -12.2 | · | -103.5 | · | -244.0 | -304.8 | -10809.9 | 546.5 | · | · | · | |
| P / FCF | · | · | · | -101.7 | · | -230.4 | -291.1 | -4169.1 | 568.8 | · | · | · | |
| Earnings Yield | -3.5% | -65.2% | 14.9% | -0.84% | -0.23% | -0.34% | · | · | · | · | · | · |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | $53.0K | · | $20M | $20M | $2M | $6M | $5M | |
| R&D Expense | $12M | $9M | $7M | $7M | $5M | $4M | $3M | $3M | $1M | $984.0K | $-29M | $10M | $14M | $13M | $13M | $14M | |
| SG&A Expense | $9M | $6M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | $775.0K | $-11M | $7M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $21M | $15M | $11M | $10M | $9M | $8M | $4M | $5M | $3M | $2M | $-55M | $31M | $18M | $17M | $17M | $18M | |
| Operating Income | $-21M | $-15M | $-11M | $-10M | $-9M | $-8M | $-4M | $-5M | $-3M | $-2M | $13M | $-12M | $2M | $-16M | $-12M | $-12M | |
| Other Non-op | $-8.0K | $-32.0K | $-92.0K | $34.0K | $561.0K | $224.0K | $-175.0K | $-20.0K | $64.0K | $0 | $424.0K | $506.0K | $-161.0K | $-57.0K | $-325.0K | $723.0K | |
| Pretax Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-22M | $-16M | $-13M | $-11M | $-9M | $-8M | $-4M | $-7M | $-4M | $-3M | $39M | $-11M | $4M | $-13M | $-8M | $-10M | |
| EPS (Basic) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $21.41 | $-8.70 | $3.63 | $-14.15 | $-0.11 | $-0.13 | |
| EPS (Diluted) | $-1.52 | $-1.20 | $-1.08 | $-1.03 | $-0.86 | $-0.74 | $0.12 | $-3.94 | $-2.47 | $-1.54 | $20.50 | $-8.70 | $3.62 | · | · | · | |
| Shares (Basic) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | -1,491,833 | 1,236,000 | 1,095,000 | 931,000 | -148,061,000 | 74,397,000 | |
| Shares (Diluted) | 14,356,219 | 13,085,271 | -21,879,470 | 11,064,282 | 11,052,741 | 11,013,697 | -3,084,567 | 1,770,167 | 1,770,167 | 1,770,167 | 704,980 | 1,236,000 | 1,098,000 | · | · | · | |
| EBITDA | $-21M | $-15M | · | $-10M | $-9M | $-8M | · | $-3M | $-4M | $-5M | · | $-12M | $2M | $-15M | · | $-12M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $188M | $206M | $58M | $64M | $70M | $76M | $84M | $19M | $20M | $19M | $7M | $33M | $45M | $40M | $39M | $48M | |
| Short-term Investments | $63M | $55M | · | · | · | · | · | $0 | $0 | $0 | · | $12M | $10M | $9M | $21M | $21M | |
| Receivables | · | · | $0 | $0 | $0 | $0 | $358.0K | $373.0K | $1M | $2M | $0 | $1M | $952.0K | $1M | $6M | $829.0K | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $280.0K | $649.0K | $3M | $198.0K | $9M | $11M | $11M | $3M | $8M | |
| Current Assets | $253M | $263M | $59M | $67M | $74M | $79M | $88M | · | · | · | $8M | $59M | $66M | $61M | $73M | $79M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $0 | $16M | $17M | $17M | $16M | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | $27M | $27M | $27M | $24M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | $11M | $10M | $10M | $8M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $287.0K | $1M | $1M | $1M | $1M | |
| Total Assets | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Accounts Payable | $7M | $5M | $5M | $3M | $5M | $4M | $5M | $801.0K | $969.0K | $2M | $936.0K | $3M | $8M | $6M | $4M | $4M | |
| Current Liabilities | $12M | $9M | $11M | $10M | $10M | $9M | $12M | $4M | $6M | $8M | $2M | $29M | $34M | $43M | $37M | $34M | |
| Capital Leases | $318.0K | $375.0K | $431.0K | · | · | · | $0 | · | · | · | · | $0 | $12M | $12M | $12M | $11M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Total Liabilities | $37M | $31M | $32M | $28M | $26M | $24M | $26M | · | · | · | $11M | $29M | $47M | $67M | $68M | $63M | |
| Common Stock | $14.0K | $14.0K | $12.0K | $11.0K | $11.0K | $11.0K | $11.0K | $1.0K | $1.0K | $1.0K | $0 | $99.0K | $99.0K | $74.0K | $74.0K | $74.0K | |
| Paid-in Capital | $390M | $383M | $163M | $161M | $159M | $157M | $156M | $343M | $343M | $342M | $2M | $341M | $340M | $319M | $319M | $317M | |
| Retained Earnings | $-173M | $-151M | $-135M | $-123M | $-111M | $-102M | $-94M | $-326M | $-323M | $-320M | $-76M | $-310M | $-300M | $-304M | $-290M | $-282M | |
| AOCI | $89.0K | $95.0K | $83.0K | $104.0K | $-111.0K | $-3.0K | $3.0K | $-316.0K | $-436.0K | $-346.0K | $0 | $-339.0K | $-137.0K | $-426.0K | $-254.0K | $524.0K | |
| Stockholders' Equity | $217M | $232M | $28M | $39M | $48M | $56M | $63M | $16M | $19M | $22M | $-74M | $31M | $40M | $15M | $28M | $36M | |
| Liabilities + Equity | $254M | $264M | $60M | $67M | $74M | $79M | $88M | $21M | $25M | $29M | $8M | $59M | $88M | $82M | $95M | $99M | |
| Shares Outstanding | 14,395,705 | 14,313,659 | 12,380,933 | 11,088,329 | 11,059,665 | 11,021,389 | 11,012,105 | 1,320,240 | 1,320,240 | 1,236,688 | 1,770,167 | · | 98,851,927 | 74,519,103 | 74,519,103 | 74,406,253 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $0 | $0 | $-30.0K | · | $739.0K | $758.0K | $605.0K | $575.0K | $767.0K | |
| Stock-based Comp | $5M | $3M | $2M | $2M | $1M | $1M | $268.0K | $-331.0K | $-109.0K | $146.0K | $-2M | $966.0K | $1M | $884.0K | $949.0K | $974.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-13M | $-11M | $-5M | $-8M | $-5M | $-7M | $-5M | $3M | $4M | $-1M | $20M | $-10M | $-13M | $-11M | $-13M | $-9M | |
| CapEx | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $69.0K | $67.0K | $48.0K | $-11.0K | $34.0K | |
| Investing Cash Flow | $-7M | $-55M | · | · | $0 | $0 | · | $142.0K | $2M | $9M | · | $-2M | $-1M | $12M | $1M | $5M | |
| Stock Issued | $0 | $230M | · | · | $0 | $0 | · | $0 | · | · | · | $0 | $20M | $0 | $0 | $282.0K | |
| Net Stock Activity | · | $230M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $215M | $-49.0K | $242.0K | $349.0K | $-1M | $75M | $12M | $10M | $0 | $-15M | $0 | $20M | $0 | $93.0K | $282.0K | |
| Net Change in Cash | $-19M | $148M | $-6M | $-7M | $-5M | $-8M | $69M | $5M | $5M | $-1M | $-3M | $-12M | $5M | $1M | $-10M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | $-11M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10005.7% | · | -60.5% | 10.3% | -801.2% | · | -226.6% | |
| Net Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | -9230.2% | · | -55.1% | 19.8% | -680.9% | · | -181.3% | |
| Pretax Margin | -1113.0% | -1469.4% | · | -1806.5% | -1372.6% | -1088.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1089.3% | -1384.4% | · | -1620.5% | -1340.6% | -1046.7% | · | · | · | -10062.3% | · | -60.5% | 10.3% | -769.9% | · | -226.6% | |
| ROA | -13.4% | -9.2% | · | -25.9% | -19.2% | -15.0% | · | -7.2% | -6.4% | -8.8% | · | -13.6% | 3.9% | -12.0% | · | -7.4% | |
| ROE | -16.5% | -10.9% | · | -41.3% | -28.5% | -21.1% | · | -12.3% | -12.1% | -26.2% | · | -32.5% | 9.4% | -38.3% | · | -21.7% | |
| ROIC | -9.9% | -6.4% | · | -26.3% | -19.4% | -14.2% | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.2 | 28.9 | · | 6.5 | 7.7 | 8.8 | · | · | · | · | · | 2.0 | 1.9 | 1.4 | · | 2.3 | |
| Quick Ratio | 21.0 | 28.7 | · | 6.2 | 7.3 | 8.4 | · | 4.6 | 3.3 | 2.8 | · | 1.6 | 1.6 | 1.2 | · | 2.1 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.2 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 3.4 | 0.9 | 0.8 | · | 0.0 | 0.0 | 0.0 | · | 20.8 | 18.1 | 1.4 | · | 1.4 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | · | $20M | $20M | $20M | · | $20M | $40M | $42M | · | $47M | $31M | $22M | · | $24M | |
| Net Income TTM | $-58M | $-45M | · | $-36M | $-29M | $-22M | · | $-24M | $-13M | $-22M | · | $-30M | $-29M | $-38M | · | $-42M | |
| Market Cap | $2.20B | $1.78B | · | $695M | $249M | $308M | · | $22M | $13M | $18M | · | · | $1.31B | $5.82B | · | $6.85B | |
| P/E | -33.1 | -32.5 | · | -9.5 | -2.8 | -3.2 | · | -1.0 | -1.1 | · | · | · | · | -111.5 | · | -131.4 | |
| P/S | 112.4 | 91.2 | · | 35.5 | 12.7 | 15.8 | · | 1.1 | 0.3 | 0.4 | · | · | 42.3 | 264.6 | · | 283.9 | |
| P/B | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Tangible Book | 10.1 | 7.7 | · | 18.0 | 5.2 | 5.6 | · | 1.3 | 0.7 | 0.8 | · | · | 32.4 | 376.4 | · | 191.4 | |
| P / Cash Flow | · | -164.2 | · | · | · | -45.6 | · | · | · | -2.6 | · | · | · | -529.1 | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -2.6 | · | · | · | -526.8 | · | · | |
| Earnings Yield | -3.0% | -3.1% | · | -10.5% | -35.5% | -31.1% | · | -100.4% | -92.7% | · | · | · | · | -0.90% | · | -0.76% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | — | — | $43M | $26M | $31M |
| Marża Operacyjna % | -1490.4% | — | — | -167.8% | — |
| Zysk netto | $-42M | $-17M | $19M | $-33M | $-46M |
| Rozwodniony EPS | $-3.71 | $-7.83 | $2.17 | — | $-0.71 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.2 | 7.3 | — | 2.0 | — |
| Wskaźnik Szybkości | 5.1 | 7.0 | — | 1.8 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | — | $-61M | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 211 emitentów · $1.9B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 43 (-20 vs poprzedni kw.) | 19 (-3 vs poprzedni kw.) | 86 (+21 vs poprzedni kw.) | 46 (+13 vs poprzedni kw.) | +1.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $173 512 745 | 1 135 406 | 9,19% | Akcje |
| Frazier Life Sciences Management, L.P. | $134 848 368 | 882 400 | 7,15% | Akcje |
| JENNISON ASSOCIATES LLC | $124 781 044 | 816 523 | 6,61% | Akcje |
| First Light Asset Management, LLC | $117 961 911 | 771 901 | 6,25% | Akcje |
| BVF INC/IL | $102 815 615 | 672 789 | 5,45% | Akcje |
| STATE STREET CORP | $99 817 745 | 653 172 | 5,29% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $78 517 999 | 513 794 | 4,16% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $73 175 272 | 478 833 | 3,88% | Akcje |
| FEDERATED HERMES, INC. | $66 173 352 | 433 015 | 3,51% | Akcje |
| VANGUARD GROUP INC | $51 885 966 | 495 710 | 2,75% | Akcje |
| Woodline Partners LP | $48 522 948 | 317 517 | 2,57% | Akcje |
| ORBIMED ADVISORS LLC | $44 678 455 | 292 360 | 2,37% | Akcje |
| Siren, L.L.C. | $39 348 858 | 257 485 | 2,09% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $39 149 734 | 256 182 | 2,07% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $36 385 548 | 238 031 | 1,93% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $35 375 385 | 231 484 | 1,87% | Akcje |
| EMERALD ADVISERS, LLC | $35 070 051 | 229 486 | 1,86% | Akcje |
| FMR LLC | $32 814 733 | 214 728 | 1,74% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $31 557 391 | 253 168 | 1,67% | Akcje |
| MPM BIOIMPACT LLC | $31 179 406 | 204 027 | 1,65% | Akcje |
| GOLDMAN SACHS GROUP INC | $28 993 469 | 189 723 | 1,54% | Akcje |
| First Turn Management, LLC | $23 908 689 | 156 450 | 1,27% | Akcje |
| Bellevue Group AG | $23 687 100 | 155 000 | 1,26% | Akcje |
| Caption Management, LLC | $21 394 800 | 140 000 | 1,13% | Opcja sprzedaży |
| EMERALD MUTUAL FUND ADVISERS TRUST | $19 843 219 | 129 847 | 1,05% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $19 707 973 | 128 962 | 1,04% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18 430 092 | 120 600 | 0,98% | Opcja kupna |
| Aberdeen Group plc | $18 374 771 | 120 238 | 0,97% | Akcje |
| NEXTBio Capital Management LP | $13 739 893 | 89 909 | 0,73% | Akcje |
| Clio Asset Management LLC | $13 194 937 | 86 343 | 0,70% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 706 012 | 76 600 | 0,62% | Opcja sprzedaży |
| VANGUARD FIDUCIARY TRUST CO | $11 307 916 | 73 995 | 0,60% | Akcje |
| Avidity Partners Management LP | $10 697 400 | 70 000 | 0,57% | Akcje |
| AWM Investment Company, Inc. | $10 608 153 | 69 416 | 0,56% | Akcje |
| SEVEN GRAND MANAGERS, LLC | $9 169 200 | 60 000 | 0,49% | Akcje |
| Clearbridge Investments, LLC | $9 068 458 | 59 341 | 0,48% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $8 445 444 | 55 264 | 0,45% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $8 140 721 | 53 270 | 0,43% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $7 979 038 | 52 212 | 0,42% | Akcje |
| Ensign Peak Advisors, Inc | $7 894 681 | 51 660 | 0,42% | Akcje |
| Nicholas Investment Partners, LP | $7 597 905 | 49 718 | 0,40% | Akcje |
| Balyasny Asset Management L.P. | $6 805 992 | 44 536 | 0,36% | Akcje |
| Lisanti Capital Growth, LLC | $6 567 440 | 42 975 | 0,35% | Akcje |
| WCM INVESTMENT MANAGEMENT, LLC | $6 215 278 | 40 140 | 0,33% | Akcje |
| ROYCE & ASSOCIATES LP | $6 190 585 | 40 509 | 0,33% | Akcje |
| ORBIMED ADVISORS LLC | $6 112 800 | 40 000 | 0,32% | Opcja kupna |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $6 092 169 | 39 865 | 0,32% | Akcje |
| Apis Capital Advisors, LLC | $5 959 980 | 39 000 | 0,32% | Akcje |
| Blue Owl Capital Holdings LP | $5 541 100 | 36 259 | 0,29% | Akcje |
| FIFTH THIRD BANCORP | $5 438 100 | 35 585 | 0,29% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 979 334 | 32 583 | 0,26% | Akcje |
| FRED ALGER MANAGEMENT, LLC | $4 802 216 | 31 424 | 0,25% | Akcje |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4 786 017 | 31 318 | 0,25% | Akcje |
| CITADEL ADVISORS LLC | $4 645 728 | 30 400 | 0,25% | Opcja kupna |
| Caption Management, LLC | $4 584 600 | 30 000 | 0,24% | Opcja kupna |
| BANK OF AMERICA CORP /DE/ | $4 577 265 | 29 952 | 0,24% | Akcje |
| JANE STREET GROUP, LLC | $4 095 576 | 26 800 | 0,22% | Opcja kupna |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3 820 500 | 25 000 | 0,20% | Akcje |
| NOMURA HOLDINGS INC | $3 662 026 | 23 963 | 0,19% | Akcje |
| Legato Capital Management LLC | $3 589 741 | 23 490 | 0,19% | Akcje |
| TD Asset Management Inc | $3 476 044 | 22 746 | 0,18% | Akcje |
| ACT CAPITAL MANAGEMENT, LLC | $3 438 450 | 22 500 | 0,18% | Akcje |
| Swiss National Bank | $2 964 708 | 19 400 | 0,16% | Akcje |
| Informed Momentum Co LLC | $2 880 504 | 18 849 | 0,15% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $2 762 833 | 18 079 | 0,15% | Akcje |
| F/m Investments LLC | $2 666 098 | 17 446 | 0,14% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 658 610 | 17 397 | 0,14% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 375 587 | 15 545 | 0,13% | Akcje |
| CITIGROUP INC | $2 270 905 | 14 860 | 0,12% | Akcje |
| ALPS ADVISORS INC | $2 193 884 | 14 356 | 0,12% | Akcje |
| Capricorn Fund Managers Ltd | $2 152 928 | 14 088 | 0,11% | Akcje |
| RHUMBLINE ADVISERS | $2 067 339 | 13 528 | 0,11% | Akcje |
| Trexquant Investment LP | $2 062 306 | 13 495 | 0,11% | Akcje |
| CITADEL ADVISORS LLC | $2 032 506 | 13 300 | 0,11% | Opcja sprzedaży |
| BlackRock, Inc. | $1 945 093 | 12 728 | 0,10% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 878 769 | 12 294 | 0,10% | Akcje |
| OAK RIDGE INVESTMENTS LLC | $1 839 647 | 12 038 | 0,10% | Akcje |
| Cresset Asset Management, LLC | $1 777 144 | 11 629 | 0,09% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $1 762 167 | 11 531 | 0,09% | Akcje |
| Rafferty Asset Management, LLC | $1 736 188 | 11 361 | 0,09% | Akcje |
| Bank of New York Mellon Corp | $1 633 340 | 10 688 | 0,09% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $1 593 913 | 10 430 | 0,08% | Akcje |
| Mariner, LLC | $1 583 364 | 10 361 | 0,08% | Akcje |
| Knights of Columbus Asset Advisors LLC | $1 532 937 | 10 031 | 0,08% | Akcje |
| XTX Topco Ltd | $1 354 138 | 8 861 | 0,07% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $1 284 605 | 8 406 | 0,07% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $1 208 195 | 7 906 | 0,06% | Akcje |
| MetLife Investment Management, LLC | $978 812 | 6 405 | 0,05% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $977 895 | 6 399 | 0,05% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $976 825 | 6 392 | 0,05% | Akcje |
| Vanguard Global Advisers, LLC | $948 859 | 6 209 | 0,05% | Akcje |
| ASPIRIANT, LLC | $894 303 | 5 852 | 0,05% | Akcje |
| PROFUND ADVISORS LLC | $879 173 | 5 753 | 0,05% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $873 519 | 5 716 | 0,05% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $859 462 | 6 895 | 0,05% | Akcje |
| Penn Capital Management Company, LLC | $841 427 | 5 506 | 0,04% | Akcje |
| ExodusPoint Capital Management, LP | $839 593 | 5 494 | 0,04% | Akcje |
| Squarepoint Ops LLC | $790 996 | 5 176 | 0,04% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $787 176 | 5 151 | 0,04% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $722 991 | 4 731 | 0,04% | Akcje |
Insiderzy spółki 23 insiderów · 10 dyrektorzy generalni · 15 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kaupinen Wes | President and CEO | 5 lutego 2026 A | — | 0 | 0 | $0 |
| Stephen S. Yoder | Chief Executive Officer | 23 lutego 2017 A | 6 000 | 0 | 0 | $0 |
| Matthew E Korenberg | CFO, Treasurer | 12 czerwca 2026 M | 1 000 | 0 | 0 | $0 |
| Allan Reine | SVP and Chief Financial Officer | 17 sierpnia 2017 P | 65 000 | 0 | 0 | $0 |
| Darlene M Deptula-Hicks | SVP, Chief Financial Officer | 13 czerwca 2016 P | 5 000 | 0 | 0 | $0 |
| Kathleen Goin | Chief Operating Officer | 15 lipca 2026 M | 0 | 0 | 25 | $-4 196 766 |
| Ashley Hartmann Kline | Chief Commercial Officer | 5 lutego 2026 A | — | 0 | 0 | $0 |
| Jeffrey S Martini | Chief Scientific Officer | 5 lutego 2026 A | — | 0 | 0 | $0 |
| Louis Matis | SVP, Chief Development Officer | 23 lutego 2017 A | 10 000 | 0 | 0 | $0 |
| Claude Knopf | Chief Business Officer | 28 listopada 2016 A | — | 0 | 0 | $0 |
| Matthew Pauls | Dyrektor | 29 czerwca 2026 A | — | 0 | 0 | $0 |
| Tadd S. Wessel | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| John Doux | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Todd C Davis | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| George M Jenkins | Dyrektor | 10 czerwca 2026 A | 187 616 | 2 | 0 | $549 974 |
| Christopher P Kiritsy | Dyrektor | 10 czerwca 2026 A | 5 000 | 0 | 0 | $0 |
| Elaine J Heron | Dyrektor | 10 czerwca 2026 A | 47 812 | 1 | 0 | $300 000 |
| James A Geraghty | Dyrektor | 17 sierpnia 2017 P | 10 000 | 0 | 0 | $0 |
| Chau Quang Khuong | Dyrektor | 25 lipca 2017 A | 65 398 | 0 | 0 | $0 |
| Michael Richman | Dyrektor | 25 lipca 2017 A | — | 0 | 0 | $0 |
| Jean-Pierre Bizzari | Dyrektor | 25 stycznia 2017 A | — | 0 | 0 | $0 |
| Steven Prelack | Dyrektor | 25 stycznia 2017 A | — | 0 | 0 | $0 |
| Julian Adams | Dyrektor | 25 stycznia 2017 A | — | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 3 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Kaupinen Wes, Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Christine L. Kaupinen, Christine L. Kaupinen 2019 Irrevocable Trust dated February 28, 2019, Michael Christopher | 20 grudnia 2024 | 14,60% | Pierwotne zgłoszenie | — | SEC |
| Biotechnology Value Fund, L.P., BVF I GP LLC, Biotechnology Value Fund II, L.P., BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP Holdings LLC, BVF Partners L.P., BVF Inc., Mark N. Lampert ×2 zgłoszenia | 17 sierpnia 2023 | — | Pierwotne zgłoszenie | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP III LLC ×10 zgłoszenia | 27 września 2018 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 30 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 1,95% | 17 254 NS | 31 maja 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,03% | 14 096 NS | 31 maja 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,96% | 2 798 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,39% | 15 705 NS | 30 kwietnia 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 22 955 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,10% | 98 816 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 11 762 SH | 8 sierpnia 2026 | Dziennie |
| SMMV · iShares Trust | 0,09% | 1 761 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,05% | 277 644 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 63 184 SH | 8 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,05% | 4 017 NS | 31 maja 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 3 330 NS | 30 kwietnia 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 1 578 SH | 8 sierpnia 2026 | Dziennie |
| ISCB · iShares Trust | 0,02% | 450 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,02% | 364 NS | 31 maja 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 1 030 SH | 8 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 4 496 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 113 556 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,02% | 30 157 SH | 8 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,02% | 667 SH | 8 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,01% | 285 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 288 NS | 31 maja 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 3 843 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 7 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 232 NS | 31 maja 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 3 380 SH | 8 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 14 741 SH | 8 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 218 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 388 390 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 904 SH | 8 sierpnia 2026 | Dziennie |